MDGL — Madrigal Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapNeutral

Annual balance sheet for Madrigal Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	270	359	634	926	984
Net Total Accounts Receivable
Net Total Receivables	—	—	—	53.8	134
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	272	361	637	1,033	1,246
Net Property, Plant And Equipment	1.65	1.2	3.27	4.59	6.44
Net Intangible Assets
Total Assets	273	363	641	1,042	1,260
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	76.8	116	119	169	310
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	77.2	165	235	288	657
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	196	197	405	754	603
Total Liabilities & Shareholders' Equity	273	363	641	1,042	1,260
Total Common Shares Outstanding
Total Preferred Shares Outstanding